Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has significant investment plans for its facility in Madhya Pradesh including setting up of a new research facility in Madhya Pradesh. The company had recently signed an agreement with ICMR and Madhya Pradesh government to work towards eradicating malaria. The company is present in the state because of Ranbaxy, which has a large manufacturing facility in Madhya Pradesh state. Sun Pharma had acquired Ranbaxy in a $4-billion deal in 2014.

Besides, the pharma major has completed the divestment of its seven prescription brands in India to RPG Life Sciences. The company has divested the same after receiving approval of the Competition Commission of India and completion of all the necessary formalities for closure of the transaction.

Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company.